Targeting polycomb repressor complex 2‐mediated bivalent promoter epigenetic silencing of secreted frizzled‐related protein 1 inhibits cholangiocarcinoma progression

Guanhua Wu(Tongji Hospital), Yongjun Chen(Tongji Hospital), Junsheng Chen(Nanfang Hospital), Xin Wang(Harbin Medical University), Qi Wang(Union Hospital), Da Wang(Shenyang Pharmaceutical University), Bing Wang(Universidad del Noreste), Wenhua Huang(Third Affiliated Hospital of Southern Medical University), Wenzheng Liu(Tongji Hospital), Fei Xiong(Tongji Hospital)
Clinical and Translational Medicine
December 1, 2023
10.1002/ctm2.1502
Cited by 24

Related Papers

Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells
|Cell Reports|2022|465
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
A Comparison of Whole-Genome Shotgun-Derived Mouse Chromosome 16 and the Human Genome
|Science|2002|370
Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
|Alzheimer s & Dementia|2020|256
Gene body methylation in cancer: molecular mechanisms and clinical applications
|Clinical Epigenetics|2022|155